Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Format: Artigo
Jezik:Russo
Izdano: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Serija:Vestnik Transplantologii i Iskusstvennyh Organov
Teme:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Online pristup:https://journal.transpl.ru/vtio/article/view/1194
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items